Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Erice

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
AIDS (London, England)|April 15, 1999
Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavirP Tebas, A K Patick, E M Kane, et al.
The Journal of Infectious Diseases|May 1, 1997
Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patientsA Erice, C Gil-Roda, J L Pérez, et al.
The Journal of Infection|November 1, 1990
Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDSC Montalban, J L Calleja, A Erice, et al.
Journal of Clinical Microbiology|March 1, 1997
Standardized peripheral blood mononuclear cell culture assay for zidovudine susceptibility testing of clinical human immunodeficiency virus type 1 isolates: effect of reducing the numbers of replicates and concentrationsI C Marschner, D L Mayers, A Erice, et al.
Journal of Clinical Microbiology|November 11, 1992
Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytesA Erice, M A Holm, P C Gill, et al.
The Journal of Infectious Diseases|March 1, 1995
Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistanceS Chou, A Erice, M C Jordan, et al.
Journal of Clinical Microbiology|April 3, 2001
Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasmaA M Caliendo, R Schuurman, B Yen-Lieberman, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral proteinA Erice, H H Balfour, D E Myers, et al.
The Journal of Infectious Diseases|March 1, 1995
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infectionD Havlir, S H Cheeseman, M McLaughlin, et al.
AIDS (London, England)|October 6, 1999
Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study teamR W Price, C T Yiannoutsos, D B Clifford, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
AIDS (London, England)|April 15, 1999
Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavirP Tebas, A K Patick, E M Kane, et al.
The Journal of Infectious Diseases|May 1, 1997
Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patientsA Erice, C Gil-Roda, J L Pérez, et al.
The Journal of Infection|November 1, 1990
Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDSC Montalban, J L Calleja, A Erice, et al.
Journal of Clinical Microbiology|March 1, 1997
Standardized peripheral blood mononuclear cell culture assay for zidovudine susceptibility testing of clinical human immunodeficiency virus type 1 isolates: effect of reducing the numbers of replicates and concentrationsI C Marschner, D L Mayers, A Erice, et al.
Journal of Clinical Microbiology|November 11, 1992
Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytesA Erice, M A Holm, P C Gill, et al.
The Journal of Infectious Diseases|March 1, 1995
Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistanceS Chou, A Erice, M C Jordan, et al.
Journal of Clinical Microbiology|April 3, 2001
Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasmaA M Caliendo, R Schuurman, B Yen-Lieberman, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1993
Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral proteinA Erice, H H Balfour, D E Myers, et al.
The Journal of Infectious Diseases|March 1, 1995
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infectionD Havlir, S H Cheeseman, M McLaughlin, et al.
AIDS (London, England)|October 6, 1999
Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study teamR W Price, C T Yiannoutsos, D B Clifford, et al.
Pageof 8